Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, Thaiss CA, Reuben A, Livny J, Avraham R, Frederick DT, Ligorio M, Chatman K, Johnston SE, Mosher CM, Brandis A, Fuks G, Gurbatri C, Gopalakrishnan V, Kim M, Hurd MW, Katz M, Fleming J, Maitra A, Smith DA, Skalak M, Bu J, Michaud M, Trauger SA, Barshack I, Golan T, Sandbank J, Flaherty KT, Mandinova A, Garrett WS, Thayer SP, Ferrone CR, Huttenhower C, Bhatia SN, Gevers D, Wargo JA, Golub TR, Straussman R. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017 09 15; 357(6356):1156-1160.
Gedye C, Cardwell T, Dimopoulos N, Tan BS, Jackson H, Svobodová S, Anaka M, Behren A, Maher C, Hofmann O, Hide W, Caballero O, Davis ID, Cebon J. Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro. Stem Cell Rev Rep. 2016 Feb; 12(1):156-61.
Gazit R, Rechnitzer H, Achdout H, Katzenell A, Katz G, Markel G, Arnon TI, Gonen-Gross T, Mizrahi S, Gruda R, Rottem S, Mandelboim O. Recognition of Mycoplasma hyorhinis by CD99-Fc molecule. Eur J Immunol. 2004 Jul; 34(7):2032-40.